'14-day / Two-week wait'
England meets the standard for their country on the percentage of patients first seen by a specialist within two weeks of urgent GP referral for suspected cancer.
'Two-week wait' supports early diagnosis as spotting cancer early is important for improving survival, so it is important that patients with potential cancer symptoms are referred promptly.
Wales meets the standard for their country on the percentage of patients that receive their first cancer treatment within 31 days of a decision to treat, while England does not meet the standard for their country.[1,2]
The speed at which patients receive their first treatment can have a positive outcome on their clinical outcome, so it is important that patients with cancer symptoms are treated promptly.
Cancer waiting times coding and standards are different in each country and so comparisons should not be made between countries, only each country against their own measures.
Acute Leukaemia, Waiting Times, UK countries, 2014-15
|'14-day wait': seen by specialist following referral||Performance||94.1%|
|Performance against standard||Meets standard|
|'31-day wait': receipt of first treatment following decision to treat||Performance||78.3%||100%|
|Performance against standard||Does not meet standard||Meets Standard|
Data too small for '62-day wait' for Wales and not available for England, Scotland or NI.
About this data
Data is for UK, 2014-2015, ICD-10 C91.0 and C92.0
Cancer waiting times statistics are for patients who entered the health care system within financial year 2014-15. AML is part of the group 'Acute leukaemia' for cancer waiting times data. Codes vary per country but broadly include: acute lymphoblastic, myeloid and monocytic leukaemia and some other leukaemia of specific or unspecified cell type.